Article Text

Download PDFPDF

OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study
  1. R Stevens1,
  2. D Petersen2,
  3. J Ervin3,
  4. J Nezzer4,
  5. Y Nieves4,
  6. J Campbell1,
  7. K Guedes1,
  8. R Burges1,
  9. P Hanson1
  1. 1Centrexion Therapeutics, Boston
  2. 2Noble Clinical Research, LLC, Tucson
  3. 3The Center for Pharmaceutical Research, Kansas City
  4. 4Premier Research, Durham, United States

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.